Table 1. Characteristics of patients... | American Society of Hematology

Table 1.

Characteristics of patients with MCL

Patient	Status	Age	Sex	sIg	Blastoid variant	Ki67⁺ (%)	CD19⁺CD5⁺ (% in PB)	CD5 (ratio MFI)
1	D	67	M	κ	No	ND	60	21.0
2	R	86	M	κ	ND	ND	50	7.1
3	D	73	M	ND	ND	ND	80	16.8
4	R	80	F	κ	No	ND	80	7.9
5	D	74	F	κ	No	10	85	17.6
6	R	62	M	λ	Yes	90	80	18.3
7	D	61	F	λ	ND	ND	28	25.6
8	R	67	M	λ	ND	ND	33	8.8
10	D	69	F	κ	No	ND	60	4.0
11	R	73	F	κ	No	ND	60	5.2
12a	D	69	F	κ	No	30	22	7.5
12b	D	69	F	κ	No	ND	68	30.2
13	D	73	M	κ	No	30	55	3.5
14	R	73	M	λ	ND	ND	70	16.0
15	R	79	F	κ	Yes	40	85	84.3
16	R	73	F	κ	Yes	40	90	22.0
17	D	82	F	κ	ND	ND	33	1.7
18	D	76	M	κ	No	30	25	18.4
19	R	81	M	κ	ND	ND	22	5.0
20	R	72	M	κ	Yes	65	67	16.7
21	D	70	F	λ	ND	ND	75	1.3
22	D	75	M	ND	Yes	70	84	60.0

Patient	Status	Age	Sex	sIg	Blastoid variant	Ki67⁺ (%)	CD19⁺CD5⁺ (% in PB)	CD5 (ratio MFI)
1	D	67	M	κ	No	ND	60	21.0
2	R	86	M	κ	ND	ND	50	7.1
3	D	73	M	ND	ND	ND	80	16.8
4	R	80	F	κ	No	ND	80	7.9
5	D	74	F	κ	No	10	85	17.6
6	R	62	M	λ	Yes	90	80	18.3
7	D	61	F	λ	ND	ND	28	25.6
8	R	67	M	λ	ND	ND	33	8.8
10	D	69	F	κ	No	ND	60	4.0
11	R	73	F	κ	No	ND	60	5.2
12a	D	69	F	κ	No	30	22	7.5
12b	D	69	F	κ	No	ND	68	30.2
13	D	73	M	κ	No	30	55	3.5
14	R	73	M	λ	ND	ND	70	16.0
15	R	79	F	κ	Yes	40	85	84.3
16	R	73	F	κ	Yes	40	90	22.0
17	D	82	F	κ	ND	ND	33	1.7
18	D	76	M	κ	No	30	25	18.4
19	R	81	M	κ	ND	ND	22	5.0
20	R	72	M	κ	Yes	65	67	16.7
21	D	70	F	λ	ND	ND	75	1.3
22	D	75	M	ND	Yes	70	84	60.0

Ki67 expression was determined in CCND1⁺ cells by immunohistochemistry. All but 1 (12b, pleural effusion) sample was obtained from PB.

D, diagnosis; F, female; M: male; MFI, mean fluorescence intensity; ND, not determined; R, relapse.